TW200808963A - Biochip - Google Patents

Biochip Download PDF

Info

Publication number
TW200808963A
TW200808963A TW95129607A TW95129607A TW200808963A TW 200808963 A TW200808963 A TW 200808963A TW 95129607 A TW95129607 A TW 95129607A TW 95129607 A TW95129607 A TW 95129607A TW 200808963 A TW200808963 A TW 200808963A
Authority
TW
Taiwan
Prior art keywords
substrate
biochip
flow port
flow
chamber
Prior art date
Application number
TW95129607A
Other languages
Chinese (zh)
Other versions
TWI396740B (en
Inventor
Chung-Cheng Chang
Jau-Der Chen
Bo-Tai Chen
Original Assignee
Chung-Cheng Chang
Jau-Der Chen
Bo-Tai Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chung-Cheng Chang, Jau-Der Chen, Bo-Tai Chen filed Critical Chung-Cheng Chang
Priority to TW95129607A priority Critical patent/TWI396740B/en
Publication of TW200808963A publication Critical patent/TW200808963A/en
Application granted granted Critical
Publication of TWI396740B publication Critical patent/TWI396740B/en

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention relates to a biochip used in nucleic acid hybridization. The biochip of this invention comprises a cavity like hybridization chamber installed in the biochip, a substrate with holes is clipped and installed in the hybridization chamber, and at least a first flow channel and at least a second flow channel are installed and connected to the hybridization chamber. The reaction solution may flow into at least one of the flow channel, then through holes inside the substrate, and after that discharge through at least one of the rest of the flow channel; wherein the reaction area for the reaction solution may be increased by holes inside the substrate, the sensitivity of the reaction may be improved, the diffusion distance for reaction molecules may be decreased by the restriction of the space inside the substrate, and the hybridization time may be reduced.

Description

200808963 九、發明說明: 【發明所屬之技術領域】 本發明係關於-種生物晶片,尤其是關於—種利用於 核酸雜交反應(Hybridization)之生物晶片。 【先前技術】 利用探針(probe)核酸與待分析核酸進行雜交配對, 確認樣本DNA是否具有所欲基因或核酸片段 用之方法之…習知雜交反應分析主要利用印潰法 與轉>貝法將待分析核酸移轉至—例如薄膜之基質上,而後 以具專(spedfleity)的探針核酸進行雜交配對反應, 再進-步藉由探針核酸所標記之顯示分子,以呈色、冷光 或放射顯料顯示方式呈現出雜交反應絲。 " ” ^反應所奴刀析之待分析核酸若係由電泳膠體轉 ’再與探針進行雜交反應者,稱之為南方轉潰 者,目IS咖bk>tting) ’若係對轉印之RNA進行雜交反應 將待為北柳ΜblGtting)。其他直接 ^:析核酸滴放於_者,以其滴放之翻而分別稱之 細紋狀與塊狀印潰法(-·/-·/_制ng)。 經過電IS分:紋狀等印潰法’因待分析核酸無須 分析y 1 °直接進行轉印之步驟,故可縮短操作 二且因其無糊關電泳與相《的溶液試 大批較為經濟’故常用在-般定性分析或 5 200808963 習知印潰分析方法,係在一薄膜表面滴放以待分析核 酸後,利用加熱或是紫外光照射,使待分析核酸穩固交聯 (crosslink)於薄膜表面,藉以於後續與探針核酸反應後 之清洗反應時,不會被沖刷下來。於習知反應條件下,由 於待分析核酸係滴放於一濕潤之薄膜表面,使其於此濕潤 表面上進行擴散作用而吸附於該表面上,因此,大部分的200808963 IX. INSTRUCTIONS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a biochip, and more particularly to a biochip for use in nucleic acid hybridization (Hybridization). [Prior Art] Using a probe nucleic acid to hybridize with a nucleic acid to be analyzed, and confirming whether the sample DNA has a desired gene or a nucleic acid fragment. Conventional hybridization reaction analysis mainly utilizes the method of printing and pulsing The method transfers the nucleic acid to be analyzed to, for example, a substrate of a film, and then performs a hybridization pairing reaction with a probe nucleic acid having a spedfleity, and further proceeds to a color by the display molecule labeled by the probe nucleic acid. The cold light or radioactive display shows a hybridization reaction filament. " ” ^Responsible for the analysis of the nucleic acid to be analyzed if the nucleic acid is converted by electrophoresis colloid and then hybridized with the probe, called the southern smasher, the eye IS coffee bk> gt) The hybridization reaction of the RNA will be blGtting for the northern willow. Other direct ^: the nucleic acid is dropped on the _, and the fine-grained and block-like printing method is called by the drip-distribution (-·/-· /_制ng). After the electric IS: striated and other printing method 'Because the nucleic acid to be analyzed does not need to analyze the y 1 ° direct transfer step, it can shorten the operation of the second and because of its pasteless electrophoresis and phase The solution test is relatively economical, so it is commonly used in the qualitative analysis or 5 200808963. The method is to discriminate the nucleic acid to be analyzed by using a heating or ultraviolet light. Crosslinking on the surface of the film, so as not to be washed away after the subsequent washing reaction with the probe nucleic acid. Under the conventional reaction conditions, since the nucleic acid to be analyzed is dropped on the surface of a wet film, It is diffused on the wet surface and adsorbed on On the surface, therefore, most of the

待分析核酸多係固定附著於薄膜表面以及表面鄰近之孔 洞中’使其所得固定之待分析核酸分子數係有限,則所產The nucleic acid to be analyzed is fixedly attached to the surface of the film and to the pores adjacent to the surface, and the number of nucleic acid molecules to be analyzed which are fixed is limited, and the nucleic acid molecule is produced.

生(雜父訊號強度亦將較為微弱,如此對於樣本量較少或 分子較長之待分析核酸而言,其反應靈敏度將大幅降低。 此外,當加入習知含有阻斷劑(bl〇cking reagem)之探針 核酸溶液進行雜交崎反糾,探針鋪亦如同待分析核 酸丄僅能於薄縣面騎擴散作用,_布_動方式移 動尋找可她對之待分析減。因此,f知滅雜交反應 需顧較,並綠f長軒數何以上 ^日守間’對於_多急於知曉檢測結果的試驗,即無法於短 70▲此外,對於一些較簡單的核酸定性檢測,若 仍須花^目當多時間與試劑去試驗,亦是相當不經濟。因 二::t速,能夠簡化印潰分析所需步驟與時間,並 p兼顧低背景雜之印潰分憾置或方法,對於—㈣ ==批次檢測,都可有效縮短試 ‘ 同日守大幅降低所需耗費之材料成本。 【發明内容】 200808963Health (the intensity of the heterogeneous signal will also be weak, so the sensitivity of the reaction will be greatly reduced for the nucleic acid to be analyzed with a small sample size or a long molecule. In addition, when adding a conventional blocker (bl〇cking reagem) The probe nucleic acid solution is subjected to hybridization and anti-correction, and the probe is also like the nucleic acid to be analyzed, which can only be used for the diffusion of the surface of the thin county, and the movement of the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The hybridization reaction needs to be taken care of, and the number of green f long Xuan Xu and above ^ Day Shoujian 'for _ more eager to know the test results of the test, that is, can not be short 70 ▲ In addition, for some simple nucleic acid qualitative test, if still It is quite uneconomical to spend more time and reagents on the test. Because of the second::t speed, it can simplify the steps and time required for the analysis of the break, and take into account the low background miscellaneous marks or the method. For - (4) == batch detection, it can effectively shorten the cost of materials required to reduce the cost of the same day. [Summary of Contents] 200808963

八不Htf知進行雜交反應時,待分析鋪或探針核酸 斜,祐1藉由自然之布朗運動方式進行移動與鹼基配 、e ‘乂反應所需時間長達十數小時以上所帶來之耗時 問題’同時使更多的待分析減能_著固定於基質表面 /、内使增加配對分子之數目而增加反應靈敏度,本發 明於此提供—種可進行雜交反紅生物晶Μ,藉由生物^ ^内部空間之限制’使進行雜交反應之驗得進入基質内 Ζ,使待分析核酸或探針核酸分子能夠在極短時間内於基 ^孔洞内完全擴散並完祕基崎之雜交反應。此外,於 抓體加>1之情形下’待分析核酸或探針核酸分子並能夠迅 速私動,且因其能流人基質内部,擴增其附著或反應面 積,故而一方面可增加配對核酸分子之數目而提升檢測靈 敏度,:方面則可藉由流動之移動方式,加速完成鹼基配 對同8守使清洗溶液亦得深入基質内部,沖洗掉基質内部' 未配對之操針核酸,進而改善清洗反應之清潔度 ,同時降 低反應背景值。 基於上述的目的,本發明提供一種生物晶片,包括: 該生物晶片内所設呈空腔狀之一雜交室,該雜交室内夾設 有一具孔洞之基質,該雜交室分別連通設置有至少一第一 流通口與至少一第二流通口,藉以使反應溶液由其中至少 一流通口注入後流經該基質内部而由其餘至少一流通口 流出。其中,該生物晶片更可由一上基板與一下基板所組 構,該上基板與該下基板係上下相疊合連接,該二者間形 成有該雜交室,該雜交室内夾設有具孔洞之該基質,該雜 7 200808963 流通口’該雜交室於When the Hbf is known to carry out the hybridization reaction, the analysis or the probe nucleic acid is inclined, and the time required for the movement and the base pairing and the e'乂 reaction by the natural Brownian motion is as long as more than ten hours. The time-consuming problem of 'while making more energy to be analyzed_fixed on the surface/inside of the substrate increases the number of pairing molecules to increase the sensitivity of the reaction, and the present invention provides a hybrid anti-red biocrystal, By the limitation of the internal space of the organism, the detection of the hybridization reaction is carried out into the matrix, so that the nucleic acid or the probe nucleic acid molecule to be analyzed can be completely diffused in the pores in a very short time and complete. Hybridization reaction. In addition, in the case of the grasping body plus >1, the nucleic acid or probe nucleic acid molecule to be analyzed can be rapidly mobilized, and because it can flow inside the matrix, the attachment or reaction area is amplified, so that the pairing can be increased on the one hand. The number of nucleic acid molecules increases the sensitivity of detection. On the other hand, by means of the movement of the flow, the base pairing is accelerated, and the cleaning solution is also penetrated into the interior of the matrix, and the unpaired needle nucleic acid inside the matrix is washed away. Improve the cleanliness of the cleaning reaction while reducing the background value of the reaction. Based on the above object, the present invention provides a biochip, comprising: a hybrid chamber in a cavity shape in the biochip, wherein the hybrid chamber is provided with a matrix of holes, and the hybrid chambers are respectively provided with at least one a flow port and at least one second flow port, whereby the reaction solution is injected from at least one of the flow ports and flows through the inside of the substrate to flow out from the remaining at least one flow port. The bio-wafer may be formed by an upper substrate and a lower substrate. The upper substrate and the lower substrate are vertically connected to each other, and the hybridization chamber is formed therebetween, and the hybrid chamber is provided with a hole. The matrix, the hybrid 7 200808963

雜父室所設形狀與厚度並未設有特別的限制,可配合 基質㈣龍整製作,基質缝交室之-側朗可留有-預定見度之郎:’歧應溶液得由基質之側邊進入基質 中。此外,第-流通口可連通開設於該雜交室中心點處之 上方’但其開設位置與數目並不僅限於此。另,第一流通 口、第二流通口與雜交室間可進—步連通設置—微流道, 藉以透過微流道施壓於反應溶液,使反應溶液快速通過基 質内部,雜較應鱗。基質於反麵可呈乾燥狀,使 於溶液注人時得同時藉由毛細現象之吸引力,迅速進入基 貝内4。基貝之孔洞直梭約係至5〇叫,使核酸得通 透其中’但其驗並不僅限於此,而其材㈣可為尼龍膜 (nylon membrane )或硝化纖維紙(nitr〇ceUul〇se membrane),但並不以此為限。 藉由本發明之生物晶片,待分析核酸溶液可由任一或 數個流通口送入雜交室中為基質所吸附,由於待分析核酸 可進入基質内部,因而可增加所得固定之待分析核酸分子 數,而增加其測試靈敏度。待分析核酸固定後,亦可由任 一或數個流通口送入探針核酸溶液,使探針核酸進入雜交 室之基質中,並與待分析核酸進行鹼基配對。由於探針核 酸可輕易在基質微小孔洞中移動,因此可迅速完成配對步 驟。其後進一步可由任一或數個流通口注入清洗溶液進行 清洗反應,基於探針核酸可輕易在基質微小孔洞中移動的 8 200808963 =理m絲謂未輯結合之料 料_’因此可快速、徹底地完成清洗= 細紐所而反應訏間,並降低其背景雜訊值。 本發明同時提供_種生物晶片,其包括—上基板與一 下基板,該上基板與該下基板係上下相疊合連接,該二者 =形成有-雜交室,該雜交室内上下夾設有_具孔洞之基 質,該上基板底緣於與該雜交室相接處突出有複數個小凸 柱,該些小凸柱端部係與裝設於該雜交室内之該基質表面 相觸接,此外,該雜交室向該上基板連通有至少一第一流 通口,該雜交室於側邊則連通有至少一第二流通口,該第 二流通口係與該些小凸柱間所間隔之空間相連通。藉由第 二流通口與該些小凸柱間所間隔空間之相連通,使由第二 流通口注入之溶液得經由小凸柱間之空間進入基質之 中,而擴大溶液得進入基質之面積,進而增加該溶液穿透 基質之效率與速度,使反應更為迅速而完全。 前述生物晶片,除為雙層之上基板與下基板外,亦可 由上基板以及頂基板與底基板所構成之下基板所組構。單 層下基板或由頂基板與底基板所組構之雙層下基板,可由 雜交室連通設置一第三流通口,該第三流通口並可連通有 一第二微流道,第二微流道並連接以一第四流通口,使反 應溶液亦得由基質下方進入,而得利用於不同反應流程之 s式驗中。 以下將配合圖式進一步說明本發明的實施方式,下述 所列舉的實施例係用以闡明本發明,並非用以限定本發明 200808963 2園,任何熟習此技藝者,在㈣離本翻之 圍内,當可做些許更動與_,因此本發明之保動= 視後附之申請專利範圍所界定者為準。 &圍虽 【實施方式】 示There is no special restriction on the shape and thickness of the mixed parent room. It can be combined with the matrix (4) dragon to make the whole, and the side of the matrix seaming room can be left - the scent of the predetermined degree: 'the solution of the solution is obtained from the matrix. The sides enter the matrix. Further, the first flow port may be connected to the upper side of the center of the hybrid chamber, but the position and number of the opening are not limited thereto. In addition, the first flow port, the second flow port and the hybridization chamber can be connected to each other to form a micro flow channel, so as to apply pressure to the reaction solution through the micro flow channel, so that the reaction solution can quickly pass through the inside of the matrix, and the impurities should be scaled. The substrate can be dry on the reverse side, so that when the solution is injected, it can be quickly entered into the carbene by the attraction of capillary action. The pores of the Kibe's hole are about 5 〇, so that the nucleic acid is transparent. 'But the test is not limited to this, and the material (4) can be nylon membrane or nitril fiber paper (nitr〇ceUul〇se) Membrane), but not limited to this. With the biochip of the present invention, the nucleic acid solution to be analyzed can be introduced into the hybridization chamber by any one or several flow ports for adsorption by the matrix, and since the nucleic acid to be analyzed can enter the inside of the matrix, the number of the immobilized nucleic acid molecules to be analyzed can be increased. And increase its test sensitivity. After the nucleic acid to be analyzed is immobilized, the probe nucleic acid solution may be fed from any one or several flow ports to allow the probe nucleic acid to enter the matrix of the hybridization chamber and perform base pairing with the nucleic acid to be analyzed. Since the probe nucleic acid can easily move through the tiny holes in the matrix, the pairing step can be completed quickly. Thereafter, the cleaning solution can be further injected into the cleaning solution by any one or several flow ports, and the probe nucleic acid can be easily moved in the microscopic pores of the matrix. Thoroughly complete the cleaning = fines and react to the daytime and reduce the background noise value. The invention also provides a biochip, which comprises an upper substrate and a lower substrate, wherein the upper substrate and the lower substrate are vertically connected to each other, and the two are formed with a hybridization chamber, and the hybridization chamber is provided with upper and lower clips. a substrate having a hole, a plurality of small protrusions protruding from a bottom edge of the upper substrate, and the ends of the small protrusions are in contact with the surface of the substrate disposed in the hybridization chamber, and The hybrid chamber is connected to the upper substrate with at least one first flow port, and the hybrid chamber is connected to at least one second flow port on the side, and the second flow port is connected to the space between the small protrusions. . The second flow port is in communication with the space between the small protrusions, so that the solution injected from the second flow port can enter the matrix through the space between the small columns, and the solution solution can enter the area of the substrate. This in turn increases the efficiency and speed at which the solution penetrates the substrate, making the reaction more rapid and complete. The biochip may be composed of an upper substrate and a lower substrate and a lower substrate, in addition to the upper substrate and the lower substrate. a single-layer lower substrate or a double-layer lower substrate composed of a top substrate and a bottom substrate, and a third flow port may be connected through the hybridization chamber, and the third flow port may be connected to a second micro flow channel, the second micro flow The circuit is connected to a fourth flow port, so that the reaction solution also enters from below the substrate, and can be utilized in the test of different reaction processes. The embodiments of the present invention will be further described in conjunction with the following drawings. The following examples are set forth to illustrate the invention, and are not intended to limit the scope of the present invention, which is known to those skilled in the art. In the meantime, it is possible to make some changes and _, and therefore the protection of the present invention is subject to the definition of the scope of the patent application. & circumference [Embodiment]

看翏閱第-A ®,細縣發财簡之立體 意圖。本發明實施例中之生物晶片,包括—上基板1〇、一 2G與-基質3〇。上基板1()與下基板2()係 豐合連接’而歸3㈣係裝設於上基板ig所設之雜六 11中。 又至 請同時參閱第-A圖至第—c圖,上基板1G,其設 置有一呈圓盤腔狀之雜交室n,雜交室n所設形狀大小 與厚度,並未設有特別的限制,其亦可為四邊體空腔狀。 雜交室11中心點處穿設有一第一流通口 12,第一流通口 12開設之位置並未财制的限制,其可鋪另—流通口 設置之位置加以調整,使反應溶液之流徑能遍及整個基質 30内部,因此,第一流通口 12所設數目亦未設有特別的 限制。第一流通口 12可進一步連通接設一微流道或流通 口(圖中未不),而方便溶液之注入或各微流道間之配置。 雜父室11之側邊則可連通有一第一微流道14,第一 微流道則連通接設第二流通口 13。第一微流道14所設 數目與位置亦未設有特別的限制,同樣可依反應溶液之流 徑加以调整配置。此外,基質3〇與雜交室η侧壁間並係 留有,預定寬度之空隙15,空隙15約在〇.〇5至0·2 mm 200808963 之間,其中以o.l mm為較佳。 請繼續參閱第-A圖與第—B圖,雜交室n、第一 微流道14與第二流通σ 13,最終係形成於生物晶片之上 基板10 14下基板2〇之間。因此,所述雜交室11、第一微 流道14與第二流通口 13設置位置並不僅限於上基板10 上,其亦可設置於下基板20,或分別於上基板10與下基 板20上形成相對應之腔室、微流道或流通口,則上基板 鲁 10與下基板20連接後,即可形成前述所欲之構型。上基 板10與下基板20除如前述分開製作外,其亦可為單片之 版成型,而於製作時於其内部形成前述之雜交室η、第 一微流道14與第二流通口 13。 、生物晶片於本實施财係—微流體晶片,但並不僅限 仙此其亦可包括流道尺寸更微小之奈米流體晶片,或其 可形成本發明構型之晶片。本實施例中微流體晶片之製 γ可_ $知之材料(例如:石英或玻璃等)作為基材, t濕式蝕刻(wet etching)方式蝕刻出類似毛細管之微流 ^而後在其上方覆蓋—層石英或㈣,即可完成具有封 =微流道或腔室之晶片。其亦可利用硬性高分子,例如聚 p基丙烯酸曱酯(P〇lymethyl methacrylate,以下簡稱 、聚碳酸酯(polycarbonate,以下簡稱pc),先以 方、式餘刻在;5英材質上製作母模,再以熱壓(_⑽細) 之式於PMMA或PC上形成微流道’最後再蓋以相同材質 力下基板。另外,本發明生物晶片亦可藉由軟性高分子來 D以製備,屬於軟性高分子之聚二曱基矽氧烷 200808963 (P〇lydimethyl siloxane,以下簡稱 PDMS),因具有流動 性佳之特質,在製作過程中無須加壓母模,因此可減少傷 害母模之機會,而使其使用壽命增加,且同時可大量製 作,故PDMS係一較佳之基材材質,但並不僅限於此。 基貝30’其可為尼月I臈(nyl〇nmeinbrane)或石肖化鐵 維紙(nitrocellulose membrane )等薄膜,但並不以此為限。 尼月I膜可帶有正電荷或不帶電,尼龍膜與硝化纖維紙之孔Look at the third-intention of the first-A ®, the county. The biochip of the embodiment of the invention comprises an upper substrate, a 2G and a substrate 3A. The upper substrate 1 () and the lower substrate 2 () are connected in abundance, and the 3 (4) is mounted in the hybrid 61 provided in the upper substrate ig. Please also refer to the figures -A to -c, the upper substrate 1G, which is provided with a disk chamber-shaped hybridization chamber n, and the size and thickness of the hybridization chamber n are not particularly limited. It can also be a quadrilateral hollow. A first flow port 12 is disposed at a center point of the hybridization chamber 11. The position of the first flow port 12 is not limited by the financial system, and the position of the flow port can be adjusted to adjust the flow path of the reaction solution. There is no particular limitation on the number of the first flow ports 12 provided throughout the entire interior of the substrate 30. The first flow port 12 can be further connected to a micro flow channel or a flow port (not shown) to facilitate the injection of the solution or the arrangement between the micro flow channels. A first microchannel 14 is connected to the side of the parent compartment 11, and the first microchannel is connected to the second orifice 13. The number and position of the first microchannels 14 are not particularly limited, and can be adjusted according to the flow path of the reaction solution. Further, between the substrate 3 and the side wall of the hybridization chamber η, a gap 15 of a predetermined width is left, and the gap 15 is between about 〇5 0 0. 2 mm 200808963, wherein o.l mm is preferred. Continuing to refer to Figures -A and -B, the hybrid chamber n, the first microchannel 14 and the second flow σ 13 are ultimately formed between the substrate 104 and the lower substrate 2 of the substrate 10 14 . Therefore, the positions of the hybrid chamber 11, the first microchannel 14 and the second flow port 13 are not limited to the upper substrate 10, and may be disposed on the lower substrate 20 or on the upper substrate 10 and the lower substrate 20, respectively. When the corresponding chamber, micro flow channel or flow port is formed, the upper substrate 10 is connected to the lower substrate 20 to form the desired configuration. The upper substrate 10 and the lower substrate 20 may be separately formed as described above, and may be formed into a single plate, and the hybrid chamber η, the first micro flow channel 14 and the second flow port 13 are formed in the interior thereof during fabrication. . The biochip is a microfluidic wafer of the present invention, but it is not limited thereto. It may also include a nanofluidic wafer having a smaller flow channel size, or a wafer which can form the configuration of the present invention. In the present embodiment, the microfluidic wafer is made of a material (for example, quartz or glass), and a wet etching method is used to etch a capillary-like microfluid and then overlying it. A layer of quartz or (4) can be used to complete a wafer with a seal = microchannel or chamber. It can also utilize a hard polymer, such as P〇lymethyl methacrylate (hereinafter referred to as polycarbonate), which is firstly engraved in a square or a pattern; The mold is then formed into a micro flow channel on the PMMA or PC by hot pressing (_(10) fine). Finally, the substrate is coated with the same material force. In addition, the biochip of the present invention can also be prepared by using a soft polymer D. P〇lydimethyl siloxane (hereinafter referred to as PDMS), which is a soft polymer, has a good fluidity and does not require a pressurizing master during the manufacturing process, thereby reducing the chance of harming the master mold. The PDMS is a better substrate material, but it is not limited to this. The Kibe 30' can be nyl〇nmeinbrane or stone Films such as nitrocellulose membranes, but not limited to them. Ni Yue I film can be positively or uncharged, and the pores of nylon membrane and nitrocellulose paper

/同直徑可為0·1至50 μπια ’其係依待分析核酸分子量 大小而選擇適用之孔徑大小,核酉复愈大時所使用之孔徑也 恩大,其中以〇.2 μιη與0 45 μιη為較佳。此外,薄膜可呈 乾燥狀,使將纽人待分析核_可迅速使其吸附於該薄 膜上。 “請參閱第-D ® ’該_本發明實施例進行雜交反應 時溶液流向之示意圖。進行雜交反前,可由第—流通口 Ο 注入待分析滅溶液τ,待分析核酸溶液τ進人雜交室u 後,由基質30中心點進入基質3〇内部,並往基質3〇外 緣流動擴散,最後流出於環繞基f 3G側邊之空隙Μ内集 中,之後經第-微流道14而由第二流通口 13排出。若= 質3〇呈乾燥狀,則待分析核酸溶液τ得更迅速為基質二 微細孔洞所產生之毛細現象所郎,而更快進人基質3〇 内部之孔财。其後,可制烘乾方式或騎”外光之 方式,將待分析核_定们Q外露之絲與其内部。 其後,由第一流通口 12注入探針核酸溶液P以進行 雜交配對反應。探針核酸上標記有顯示分子,藉以檢測雜 12 200808963 交反應之結果,該顯示分子可為呈色物質、酵素、螢光物、 放射線元素,但並不僅限於此。加入後之探針核酸溶液p , 如同前述待分析核酸溶液T之流徑,可佈滿整個基質3〇 中。倘基質於加入探針核酸溶液p前亦屬乾燥狀熊,則同 樣可使探針核酸溶液P迅速進入基質3〇内部。加入探針 核酸溶液P後,將生物晶片置於適當溫度下(例如·· 4〇~ 48 C )約數分鐘,使探針核酸尋找得相配對之待分析核酸 進行配對(annealing),即可完成鹼基配對之雜交反應 m ° 〜 雜父配對反應之後,必須將未完成配對之探針核酸洗 =、冲洗日守’可由第二流通口 13注入清洗溶液w,清洗 w彳于經過第一微流道14進入雜交室η中,其進入雜 =ns首先充滿整個空隙15’再由基質30之側邊逐漸 住,f 3G中心流動,最後由第-流通Π 12排出。由 月洗%,清洗溶液W係由整個基質邓外側進入内部沖/The same diameter can be from 0·1 to 50 μπια ', depending on the molecular weight of the nucleic acid to be analyzed, the pore size is selected, and the pore size used in the recovery of the nuclear complex is also large, of which 〇.2 μιη and 0 45 Μιη is preferred. In addition, the film can be dried so that the core to be analyzed can be quickly adsorbed onto the film. "Please refer to the -D ® 'This is a schematic diagram of the solution flow direction when the hybridization reaction is carried out in the embodiment of the present invention. Before the hybridization is reversed, the solution τ can be injected from the first flow port ,, and the nucleic acid solution to be analyzed is entered into the human hybridization chamber. After u, the center point of the substrate 30 enters the inside of the substrate 3〇, flows to the outer edge of the substrate 3〇, and finally flows out into the gap 环绕 around the side of the base f 3G, and then passes through the first-micro flow channel 14 The second flow port 13 is discharged. If the mass 3〇 is dry, the nucleic acid solution τ to be analyzed is more rapidly formed by the capillary phenomenon generated by the second fine pores of the matrix, and the pores of the matrix 3〇 are more quickly entered. Thereafter, the method of drying or riding the "outside light" method can be used to analyze the core of the Q to be analyzed and the inside thereof. Thereafter, the probe nucleic acid solution P is injected from the first flow port 12 to perform a hybridization pairing reaction. The display nucleic acid is labeled with a display molecule to detect the result of the reaction of the hybrid 12 200808963, and the display molecule may be a coloring matter, an enzyme, a fluorescent substance, or a radiation element, but is not limited thereto. The probe nucleic acid solution p after the addition, like the flow path of the nucleic acid solution T to be analyzed, can be spread over the entire matrix. If the substrate is also a dry bear before the addition of the probe nucleic acid solution p, the probe nucleic acid solution P can also rapidly enter the interior of the matrix. After the probe nucleic acid solution P is added, the biochip is placed at an appropriate temperature (for example, 4 〇 to 48 C) for about several minutes, and the probe nucleic acid is searched for the paired nucleic acid to be analyzed for annealing. Base pairing hybridization reaction m ° ~ After the parental pairing reaction, the unpaired probe nucleic acid must be washed, and the rinsed day can be injected into the cleaning solution w by the second flow port 13, and the cleaning is performed after the first micro The flow path 14 enters the hybridization chamber η, which enters the impurity = ns first fills the entire gap 15' and then gradually occupies from the side of the substrate 30, f 3G flows, and is finally discharged by the first flow enthalpy 12. By month washing %, the cleaning solution W is from the outside of the entire matrix Deng into the internal rush

口此犯夠迅速、輕易地將較小分子之探針核酸由基質 所兩,財冲出’ ^此可降低其背景雜訊值,並縮短沖洗 =間取錢探針核酸所標記之顯示分子進行债測, 即可獲致雜交反應之結果。 ^茶閱第二Α圖,該圖係本發明第二實施例之立體分 4〇了:圖。本發明實施例中之生物晶片,包括-上基板 了基板20與一基質3〇。上基板4〇與下基板2〇係 —目$合連接,而基質3()則係裝設於上基板4G所設之 13 200808963 明同4芩閱第二A圖至第二c圖,上基板40,其設 置有:呈圓盤腔狀之雜交室41,雜交室41所娜狀大小, ,未汉有彳=別的限制,其亦可為四邊體空腔狀。雜交室41 牙σ又有,第一成通口 42,第一流通口 42所設數目與開設 之位置並未設有特別的限制,其可依據另 一流通口設置之 位置加以雜’使反應溶液之流徑能遍及整個基質3〇内 部、,此外,第—流通π 42可進-步連通接設-微流道或 流通口未示),而方便溶液之注减各微流道間之This is a quick and easy way to transfer the probe nucleic acid of a smaller molecule from the matrix, and then it can reduce the background noise value and shorten the display molecule labeled by the flushing By conducting a debt test, the result of the hybridization reaction can be obtained. The tea is read in the second diagram, which is a three-dimensional diagram of the second embodiment of the present invention: Fig. The biochip in the embodiment of the present invention comprises an upper substrate, a substrate 20 and a substrate. The upper substrate 4A and the lower substrate 2 are connected to each other, and the substrate 3() is mounted on the upper substrate 4G. 13 200808963 The same as 4, the second A to the second c, The substrate 40 is provided with a hybrid chamber 41 in the shape of a disk, and the hybrid chamber 41 has a size of a na[gamma], which may be a quadrangular cavity. The hybrid chamber 41 has a tooth σ, and the first through port 42 has no special restriction on the number and opening position of the first flow port 42, and the reaction can be made according to the position of the other flow port. The flow path of the solution can be distributed throughout the entire substrate 3, and in addition, the first flow π 42 can be connected to the connection - the micro flow channel or the flow port is not shown, and the solution is convenient to reduce the flow between the micro flow channels.

配置。 上基板40底緣於與雜交室41相接處突出有複數個小 凸柱4U,為些小凸柱411 #部於生物晶片組設後,係與 裝設於雜交室41内之基質30表面相觸接。 鎿又至41之側邊則可連通有二第一微流道糾,第一 微流道44則分概通接設H通π 43。第-微流道 44所f/ί目與位置亦未設㈣別的限制 ,同樣可依反應溶 液之1加_整配置n通σ 43與第—微流道44 係與 凸柱411間所間隔之空間相連通。此外,基質 30與2室41側壁間並係留有-預定寬度之空隙45,空 隙45約在0.05至〇 2 夕戸弓 之間’其中以0.1 mm為較佳。 請T參閱第二A圖與第二㈣,雜室4 一 流通D43’最終係形成於生物晶片之上 基板訂基板2G m所述雜交室4卜第一微Configuration. A plurality of small studs 4U are protruded from the bottom edge of the upper substrate 40 at the bottom of the hybrid chamber 41. The small studs 411 are disposed on the surface of the substrate 30 disposed in the hybrid chamber 41 after being assembled on the biochip. Touch. The first micro flow path is connected to the side of the 41, and the first micro flow path 44 is connected to the H pass π 43 . The first microfluid channel 44 has no limitation on the f/muth position and the position. Similarly, the n-pass σ 43 and the first micro-channel 44 and the stud 411 can be arranged according to the reaction solution. The spaces of the spaces are connected. Further, between the substrate 30 and the side walls of the two chambers 41, a gap 45 of a predetermined width is left, and the gap 45 is preferably between 0.05 and 〇 2 戸 戸 其中, wherein 0.1 mm is preferable. Please refer to the second A diagram and the second (four), the chamber 4, the circulation D43', and finally the system is formed on the biochip. The substrate substrate 2G m is the hybrid chamber 4

流道44與第二流通D 上,其亦可設置於下基Lrt置並不僅限於上基板40 或分別於上基板40與下基 34 200808963 板20上形成相對應之腔室、微流道或流通口,則上基板 40與下基板20連接後,即可形成前迷所欲之構型。 生物晶片之製作,可利用前述習知方式製得,但並不 以此為限。基質3〇之材質、形狀與孔洞大小同樣可如前 述,並未設有特別的限制。 請參閱第二D圖’該圖係本發明第二實施例進行雜交 反應時溶液流向之示意圖。進行雜交反前,可由左側第二 藝 *通口 43注人待分析魏溶液τ,待分析喊溶液丁流 經第-微流道44進人雜交室4卜在雜交室41中,待分析 核酸溶液τ -方面充滿整個空隙45,由基f 3()側邊進入 基質3〇 _,另一方面則流至小凸411間之空間中, 而由基質30之上表面進入,往基質3〇底部流動擴散,最 後經第-微流道44由右側之第二流通口 43與第一流通口 42排出。絲質3〇呈絲狀,麟分析滅溶液了得 迅速為基質30微細孔洞所產生之毛細現象所吸引,而 • 快進入基質3〇内部之孔洞中。其後,可利用烘乾方式或 知射以备、外光之方式’將待分析核酸固定於基質外露 之表面與其内部。 其後,由第-流通口 42注入探針核酸溶液p以進 雜交配對反應。加入後之探針核酸溶液p,如同第— 例中待分析核酸溶液T之流徑,可佈滿整個基質3〇 ^ 倘基質於加入探針核酸溶液p前亦屬乾燥狀態,則同 錄針核酸溶液p迅速進碌質3G内部。加人探針^ >谷液P後,將生物晶片置於適當溫度下(例如:4〇〜抑。C义) 15 200808963 、力數为鐘,使板針核酸尋找得細晴之待分析核酸進行配 對,即可完成鹼基配對之雜交反應步驟。 雜交配對反應之後,可由左側之第二流通口 43注入 清洗溶液w,清洗溶液w經過第一微流道44流入雜交室 41中,如箾所述由基質3〇之侧邊與上表面進往基質如中 心與底部流動,最後由第-流通π 42與右侧之第二流通 口 43排出。由於清洗時,清洗溶液w係由整個基質如 侧邊以及上表面進入内部沖刷,因此能夠更迅速、更輕易 地將較小分仅探針_由基f 3G之孔射沖出,因此 了降低其月景雜訊值,並縮短沖洗所需時間。 。月芩閱第二A圖,該圖係本發明第三實施例之立體分 解示意圖。本發明實施例中之生物晶片,包括—上基板 50、——由頂基板201與底基板2〇2所組構之下基板2〇與 一基質30。上基板50與頂基板201、底基板202係上下 相疊合連接,而基質3G則係裝設於上基板5()所設之雜交 室51中。 請同時參’三Α ϋ至第三c圖,上基板5(),其設 置有壬圓盤腔狀之雜交室51,雜交室51所設形狀大小, ,未汉有制雜制,其亦可為四邊體空腔狀。雜交室51 牙口又有第一流通口 52,第一流通口 52所設數目與開設 之位置亚未設有特別的限制,其可依據另一流通 口設置之 位置加以@整’使反應溶液之流徑能遍及整個基質内 此外,第-流通π 52可進—步連通接設—微流道或 *通口(®巾未不)’而方便溶液之注人或各微流道間之 16 200808963 配置。 上基板50底緣於與雜交室相接處突出有複數個小 凸柱511 m;}:主511端部於生物晶片組設後,係與 裝設於雜交室51内之基質3〇表面_接。 雜交室51之侧邊則可連通有二第-微流道54,第-微流道54則分別連通接設—第二流通口 53。第一微流道 54所設數目與位置亦未設有特別的限制 ,同樣可依反應溶 液之流徑加以驢配置。第二流通口 Μ與第—微流道^ 係與該些小凸柱511間所間隔之空間相連通。此外,基質 30與雜乂至51侧壁間並係留有一預定寬度之空隙%,空 隙55約在0·05至0.2mm之間,其中以〇 lmn^較佳。 下基板20於本施例中係由頂基板2〇1與底基板2〇2 上下相疊合所組構。頂基板2〇1貫通有一第三流通口 2011,底基板202上則設有一與第三流通口 2〇11相對應 之第三流通口 2021。第三流通口 2〇11或2〇21可僅設置於 單層之下基板20中,抑或如本實施例設置於頂基板2〇1 與底基板202之雙層下基板2〇中。第三流通口 2021可連 通接設一第二微流道2022,再由第二微流道2022接設一 第四流通口 2023。 請繼續參閱第三A圖與第三B圖,雜交室51、第一 微流道54與第二流通口 53,最終係形成於生物晶片之上 基板50與下基板20之間。因此,所述雜交室51、第一微 流道54與第二流通口 53設置位置並不僅限於上基板5〇 上,其亦可設置於下基板20 ’或分別於上基板5〇與下基 17 200808963 板20上形成相對應之腔室、微流道或流通口,則上基板 50 =、下基板20連接後,即可形成前述所欲之構型。同樣 之狀況下,第三流通口則、施、第二微流道2〇22與 第四流通口 2023,亦可僅設置於頂基板201或底基板202 上,或相對應之頂基板2〇1、底基板2〇2間。 , 生物晶片之製作,可利用前述習知方式製得,但並不 以此為限基貝30之材質、形狀與孔洞大小同樣可如前 述,並未設有特別的限制。 _ 請參閱第三D圖,該圖係本發明第三實施例進行雜交 反應時溶液流向之示意圖。進行雜交反前,可由第四流通 二2023注入待分析核酸溶液τ,待分析核酸溶液τ並經 第二微流道2022、第三流通口 2021與2011進入雜交室 51。在雜交室51中,待分析核酸溶液τ由基質3〇底部中 心點進入基質30 Ν部,並往基質30外緣流動擴散,其中 有些則疋從該些小凸柱511間之空間流出,最後集中於環 •、繞基質3則則邊之空隙55内,而分別由上下兩側之第—微 流道54與第二流通口 53以及第-流通口 52排出。若基 λ 30呈乾燥狀,則待分析核酸溶液τ得更迅速為基質邓 微細孔洞所產生之毛細現象所吸引,^更快進入基質孙 内部之孔洞中。其後,可利用供乾方式或照射以紫外光之 方式,將待分析核酸U定於基# 3G外露之表面與其内部。 其後’由第-流通口 52注入探針核酸溶液p以進行 鍊乂配對反應。加入後之探針核酸溶液p,如同第一實施 例中待分析核酸溶液T之流徑,可佈滿整個基質3〇中。 18 200808963 倘基質於加入探針核酸溶液P前亦屬乾燥狀態,則同樣可 使探針核酸溶液P迅速進入基質3Ό内部。加入探針核酸 溶液Ρ後’將生物晶片置於適當溫度下(例如·· 40〜48〇c) 約數分鐘’使探針核酸尋找得相配對之待分析核酸進行配 對,即可完成鹼基配對之雜交反應步驟。 雜父配對反應之後,可由第四流通口 2023注入清洗 >谷液w’清洗溶液w經過第二微流道54、第三流通口 2021 與2011,進入雜交室51中,如前所述清洗溶液w可由基 質30底部中心點進入基質3〇内部,並往基質3〇外緣流 動擴散,其中有些則是從該些小凸柱511間之空間流出, 最後集中於環繞基質30側邊之空隙55内,而分別由上下 兩侧之第一微流道54與第二流通口 53以及第一流通口52 排出。由於清洗時,清洗溶液w係由整個基質3〇下表面 進入内部沖刷,透過向外之擴散以及小凸柱511間空間之 導引流動,因此能夠輕易地將較小分子之探針核酸由基質 30之孔洞中沖出,義降低其背景雜訊值,並縮短沖洗所 需時間。 請參閱第四A圖,該圖係本發明第四實施例之立體分 解示意圖。本發明實施例中之生物晶片,包括—上基板 6〇、-由頂基板201與底基板2〇2所組構之下基板2〇與 一基質30。上基板60與頂基板2〇卜底基板2〇2係上^ 相疊合連接,喊質30則係裝設於上基板6()所設之雜交 室61中。 請同時參㈣四A ®至第四c圖,上基板6(),其設 200808963 置有一呈圓盤腔狀之雜交室61,雜交室61所設形狀大小, 並未設有特別的限制,其亦可為四邊體空腔狀。雜交室61 穿設有一第一流通口 62,第一流通口 62所設數目與開設 之位置並未設有特別的限制,其可依據另一流通口設置之 位置加以調整,使反應溶液之流徑能遍及整個基質30内 部。此外,第一流通口 62可進一步連通接設一微流道或 流通口(圖中未示),而方便溶液之注入或各微流道間之 配置。 m 雜交室61之侧邊則可連通有二第一微流道64,第一 微流道64則分別連通接設一第二流通口 63。第一微流道 64所設數目與位置亦未設有特別的限制,同樣可依反應溶 液之流徑加以調整配置。此外,基質3〇與雜交室61側壁 間並係留有一預定寬度之空隙65,空隙65約在〇 〇5至〇.2 mm之間’其中以〇·1 mm為較佳。 下基板20於本施例中係由頂基板2〇1與底基板2〇2 • 上下相疊合所組構。頂·基板201貫通有一第三流通口 2011 ’底基板202上則設有_與第三流通口 2〇11相對應 ^第二流通口 2021。第三流通口 2G11或2()21可僅設置於 單層之下基板2〇 +,抑或如本實施例設置於頂基板2〇1 與絲板202之雙層下基板2〇 +。第三流通口期可連 通接設一第二微流道2纽,再由第二微流道2022接設-第四流通口 2023。 請繼續參閱第四A圖與第四B圖,雜交室6卜第一 微流道64與第二流通口 a,曰μ〆 遇口 63取終係形成於生物晶片之上 20 200808963 ,板60與下基板20之間。因此,所述雜交室61、第一微 級迢64與第二流通口 63設置位置並不僅限於上基板⑼ 上,其亦可設置於下基板20,或分別於上基板6〇與下基 板20上形成相對應之腔室、微流道或流通口,則上基板 〇 〃下基板20連接後,即可形成前述所欲之構型。同樣 =狀况下,第二流通口 2〇11、2〇21、第二微流道與 第四飢通口 2〇23,亦可僅設置於頂基板2〇1或底基板搬 上,或相對應之頂基板201、底基板2〇2間。 • 錢晶片之製作,可利用前述習知方式製得,但並不 以此為限。基質30之材質、形狀與孔洞大小同樣可如前 述,並未設有特別的限制。 請參閱第四D圖,該圖係本發明第四實施例進行雜交 反應時溶液流向之示意圖。進行雜交反前,可由第四流通 二2023注入待分析核酸溶液τ,待分析核酸溶液^經 第二微流道2022、第三流通口 2021與2〇11進入雜交= • 61。在雜交室61中,待分析核酸溶液丁由基質3〇底 心點進入基質30内部,並往基f 30夕卜緣流動擴散:最 -集中於環繞基質30侧邊之空隙65内,而分別由上下兩他 . 之第-微流道64與第二流通口 63以及第一流通口幻= 出。若基質30呈乾燥狀,則待分析核酸溶液了得更迅、亲 為基質30微細孔洞所產生之毛細現象所吸引,而 、、 入基質30内部之孔洞中。其後,可利用烘乾方式或 以紫外光之方式,將待分析核酸固定於基質3()外= “、、寸 面與其内部。 路之表 21 200808963 約數分鐘’使探針碰尋找得相崎之待分析核酸進行配 對,即可完成鹼基配對之雜交反應步驟。 ★ ”後,由弟—流通口 62注入探針核酸溶液P以進行 雜父配對反應。加入後之探針核酸溶液p,如同第一實施 例中待分析核酸溶液T之流徑,可佈滿整個基質%中。 倘基質於加續針髓絲p前亦屬乾餘態,則同樣^ ,探針核酸溶液P迅速進人基f 3Q内部。加人探針核酸 溶液P後,將生物晶片置於適當溫度下(例如:HC )The flow channel 44 and the second flow D may be disposed on the lower substrate Lrt and are not limited to the upper substrate 40 or the corresponding substrate, the micro flow channel or the lower substrate 40 and the lower substrate 34 200808963 respectively. After the flow port is connected, the upper substrate 40 and the lower substrate 20 are connected to form a desired configuration. The production of the bio-wafer can be made by the above-mentioned conventional methods, but is not limited thereto. The material, shape and pore size of the substrate 3 can also be as described above, and are not particularly limited. Please refer to the second D diagram. This figure is a schematic diagram of the flow direction of the solution in the hybridization reaction of the second embodiment of the present invention. Before the hybridization is reversed, the Wei solution τ can be analyzed by the second art channel 4 on the left side, and the solution solution is flowed through the first microchannel 44 into the hybridization chamber 4 in the hybridization chamber 41, and the nucleic acid to be analyzed is analyzed. The solution τ - fills the entire gap 45, from the side of the base f 3 () into the matrix 3 〇 _, and on the other hand flows into the space between the small protrusions 411, and enters from the upper surface of the substrate 30 to the substrate 3 〇 The bottom flow is diffused, and finally discharged through the first microfluid 44 from the second flow port 43 on the right side and the first flow port 42. The silky 3 〇 is filamentous, and the lining analysis of the solution rapidly attracts the capillary phenomenon generated by the micropores of the matrix 30, and • quickly enters the pores inside the matrix 3 。. Thereafter, the nucleic acid to be analyzed may be immobilized on the exposed surface of the substrate and the inside thereof by means of drying or sensitization in the form of external light. Thereafter, the probe nucleic acid solution p is injected from the first flow port 42 to carry out a hybridization pairing reaction. The probe nucleic acid solution p after the addition, as in the flow path of the nucleic acid solution T to be analyzed in the first example, can cover the entire substrate 3〇 If the substrate is also in a dry state before being added to the probe nucleic acid solution p, the same needle The nucleic acid solution p quickly enters the inside of the 3G. After adding the probe ^ > Valley liquid P, the biochip is placed at an appropriate temperature (for example: 4〇~ suppression. C meaning) 15 200808963, the force is the clock, so that the plate nucleic acid is searched for the fine nucleic acid to be analyzed. Pairing can complete the base pairing hybridization reaction step. After the hybridization pairing reaction, the cleaning solution w can be injected from the second flow port 43 on the left side, and the cleaning solution w flows into the hybridization chamber 41 through the first microchannel 44, and flows from the side and the upper surface of the substrate 3〇 as described in the crucible. The substrate flows, such as the center and the bottom, and is finally discharged by the first-flow π 42 and the second flow port 43 on the right side. Since the cleaning solution w is washed by the entire substrate such as the side and the upper surface during cleaning, it is possible to more quickly and easily separate the smaller probe-only probe from the hole of the base f 3G, thereby reducing Its moon view noise value and shorten the time required for flushing. . The second A diagram, which is a schematic diagram of the stereoscopic decomposition of the third embodiment of the present invention. The biochip in the embodiment of the present invention comprises an upper substrate 50, a substrate 2 and a substrate 30 formed by the top substrate 201 and the bottom substrate 2〇2. The upper substrate 50 is vertically connected to the top substrate 201 and the bottom substrate 202, and the substrate 3G is mounted in the hybrid chamber 51 provided in the upper substrate 5 (). Please also refer to '三Α ϋ to the third c-figure, the upper substrate 5 (), which is provided with a hybrid chamber 51 having a disk-shaped cavity, and the hybrid chamber 51 is provided in a shape and size, which is not prepared by the Han Dynasty. It can be a quadrilateral hollow. The hybrid chamber 51 has a first flow port 52 in the mouth, and the number of the first flow port 52 and the position of the opening port are not particularly limited, and the reaction solution can be made according to the position of the other flow port. The flow path can be spread throughout the entire substrate. In addition, the first-flow π 52 can be connected to the micro-channel or the * port (the towel is not) to facilitate the injection of the solution or between the micro-fluids. 200808963 Configuration. The bottom edge of the upper substrate 50 protrudes from the hybridization chamber with a plurality of small protrusions 511 m;}: the main 511 end is disposed on the surface of the substrate 3 after being assembled in the biochip, Pick up. The side of the hybridization chamber 51 is connected to the second first to micro flow passages 54, and the first micro flow passages 54 are connected to the second flow passages 53 respectively. The number and position of the first microchannel 54 are not particularly limited, and the same can be configured according to the flow path of the reaction solution. The second flow port Μ and the first micro flow channel are connected to the space between the small protrusions 511. Further, the matrix 30 and the side walls of the dopants 51 are tied with a gap % of a predetermined width, and the gap 55 is between about 0.05 mm and 0.2 mm, with 〇 lmn^ being preferred. In the present embodiment, the lower substrate 20 is formed by superposing the top substrate 2〇1 and the base substrate 2〇2 on top of each other. The top substrate 2〇1 has a third flow port 2011 therethrough, and the bottom substrate 202 is provided with a third flow port 2021 corresponding to the third flow port 2〇11. The third flow port 2〇11 or 2〇21 may be disposed only in the lower substrate 20 of the single layer, or may be disposed in the double lower substrate 2 of the top substrate 2〇1 and the bottom substrate 202 as in the present embodiment. The third flow port 2021 can be connected to a second micro flow channel 2022, and the second micro flow channel 2022 can be connected to a fourth flow port 2023. Referring to FIGS. 3A and 3B, the hybridization chamber 51, the first microchannel 54 and the second flow port 53 are finally formed between the substrate 50 and the lower substrate 20 on the biochip. Therefore, the positions of the hybrid chamber 51, the first microchannel 54 and the second flow port 53 are not limited to the upper substrate 5, but may be disposed on the lower substrate 20' or the upper substrate 5 and the lower substrate, respectively. 17 200808963 A corresponding chamber, micro flow channel or flow port is formed on the plate 20, and then the upper substrate 50 = and the lower substrate 20 are connected to form the desired configuration. In the same situation, the third flow port, the second micro flow channel 2〇22 and the fourth flow port 2023 may be disposed only on the top substrate 201 or the bottom substrate 202, or the corresponding top substrate 2〇. 1. The bottom substrate is between 2 and 2. The production of the bio-wafer can be made by the above-mentioned conventional methods, but the material, the shape and the hole size of the base 30 are not limited thereto as described above, and are not particularly limited. _ Refer to the third D diagram, which is a schematic diagram of the flow direction of the solution in the hybridization reaction of the third embodiment of the present invention. Before the hybridization is reversed, the nucleic acid solution τ to be analyzed may be injected from the fourth flow through 2023, and the nucleic acid solution τ to be analyzed is introduced into the hybridization chamber 51 via the second microchannel 2022 and the third flow port 2021 and 2011. In the hybridization chamber 51, the nucleic acid solution τ to be analyzed enters the crotch portion of the matrix 30 from the bottom center point of the substrate 3, and flows to the outer edge of the substrate 30, some of which flow out from the space between the small studs 511, and finally concentrate. The ring is wound around the substrate 3 in the gap 55, and is discharged from the first to the micro flow passages 54 and the second flow port 53 and the first flow port 52 on the upper and lower sides, respectively. If the base λ 30 is dry, the τ of the nucleic acid solution to be analyzed is more rapidly attracted by the capillary phenomenon generated by the micropores of the matrix, and it is faster to enter the pores inside the matrix grandchild. Thereafter, the nucleic acid to be analyzed U can be set on the exposed surface of the base #3G and the inside thereof by means of dry mode or irradiation in the form of ultraviolet light. Thereafter, the probe nucleic acid solution p is injected from the first flow port 52 to carry out a chain-pairing reaction. The probe nucleic acid solution p after the addition, as in the flow path of the nucleic acid solution T to be analyzed in the first embodiment, can be spread over the entire matrix. 18 200808963 If the substrate is also in a dry state prior to the addition of the probe nucleic acid solution P, the probe nucleic acid solution P can also be quickly introduced into the interior of the matrix. After adding the probe nucleic acid solution, the biochip is placed at an appropriate temperature (for example, 40~48 〇c) for about several minutes to complete the base pairing by pairing the nucleic acids to be analyzed for the probe nucleic acid to be paired. Hybridization reaction step. After the mixed reaction of the parent, the cleaning solution can be injected into the fourth microchannels 2023 through the second microchannels 54, the third flow ports 2021 and 2011, and enter the hybridization chamber 51, as described above. The solution w may enter the interior of the substrate 3 from the center point of the bottom of the substrate 30 and flow to the outer edge of the substrate 3, some of which flow out of the space between the small protrusions 511, and finally concentrate on the gaps 55 around the sides of the substrate 30. The first microchannel 54 and the second flow port 53 and the first flow port 52 are respectively discharged from the upper and lower sides. Since the cleaning solution w is washed from the lower surface of the entire substrate 3 into the inner surface by the entire substrate 3, and through the outward diffusion and the space between the small protrusions 511, the probe nucleic acid of the smaller molecule can be easily used from the substrate. The 30 holes rush out, reducing the background noise value and shortening the time required for flushing. Please refer to FIG. 4A, which is a schematic diagram of the stereoscopic decomposition of the fourth embodiment of the present invention. The biochip in the embodiment of the present invention comprises an upper substrate, and a substrate 2 and a substrate 30 which are formed by the top substrate 201 and the bottom substrate 2〇2. The upper substrate 60 is superposed on the top substrate 2 and the bottom substrate 2〇2, and the shim 30 is mounted in the hybrid chamber 61 provided in the upper substrate 6(). Please refer to (4) four A ® to fourth c, the upper substrate 6 (), which is set to 200808963 with a disk chamber-shaped hybrid chamber 61, the size of the hybrid chamber 61 is set, and there is no special restriction. It can also be a quadrilateral hollow. The hybrid chamber 61 is provided with a first flow port 62. The number and opening position of the first flow port 62 are not particularly limited, and can be adjusted according to the position of the other flow port to make the reaction solution flow. The radial energy extends throughout the interior of the substrate 30. In addition, the first flow port 62 can be further connected to a micro flow channel or a flow port (not shown) to facilitate the injection of the solution or the arrangement between the micro flow channels. The first microfluid channel 64 is connected to the side of the m hybrid chamber 61, and the first microchannel 64 is connected to the second flow port 63. The number and position of the first microchannels 64 are not particularly limited, and can be adjusted according to the flow path of the reaction solution. Further, a gap 65 of a predetermined width is left between the substrate 3 and the side wall of the hybridization chamber 61, and the gap 65 is approximately between 〇5 and 〇.2 mm, wherein 〇·1 mm is preferable. In the present embodiment, the lower substrate 20 is formed by superposing the top substrate 2〇1 and the bottom substrate 2〇2. The top substrate 201 is provided with a third flow port. The bottom substrate 202 is provided with a second flow port 2021 corresponding to the third flow port 2〇11. The third flow port 2G11 or 2() 21 may be disposed only under the single layer lower substrate 2 〇 + or, as in the present embodiment, the double bottom substrate 2 〇 + disposed on the top substrate 2〇1 and the silk plate 202. The third flow channel can be connected to a second microchannel 2, and the second microchannel 2022 is connected to the fourth flow port 2023. Please continue to refer to the fourth A picture and the fourth B picture, the hybrid chamber 6 first micro flow channel 64 and the second flow port a, and the 63μ〆 encounter 63 is formed on the biochip 20 200808963, board 60 Between the lower substrate 20. Therefore, the position of the hybridization chamber 61, the first micro-stage 64 and the second flow port 63 is not limited to the upper substrate (9), and may be disposed on the lower substrate 20 or on the upper substrate 6 and the lower substrate 20, respectively. The corresponding substrate, micro flow channel or flow port is formed on the upper substrate, and then the upper substrate and the lower substrate 20 are connected to form the desired configuration. In the same state, the second flow port 2〇11, 2〇21, the second micro flow channel and the fourth hung channel 2〇23 may be disposed only on the top substrate 2〇1 or the bottom substrate, or Corresponding between the top substrate 201 and the base substrate 2〇2. • The production of money chips can be made using the above-mentioned conventional methods, but not limited to them. The material, shape and pore size of the substrate 30 can also be as described above, and are not particularly limited. Please refer to the fourth D diagram, which is a schematic diagram of the flow direction of the solution in the hybridization reaction of the fourth embodiment of the present invention. Before the hybridization is reversed, the nucleic acid solution τ to be analyzed may be injected from the fourth flow through 2023, and the nucleic acid solution to be analyzed passes through the second microchannel 2022, the third flow port 2021 and 2〇11 to enter the hybridization = 61. In the hybridization chamber 61, the nucleic acid solution to be analyzed enters the interior of the matrix 30 from the bottom of the matrix 3, and flows to the base f30: most concentrated in the gap 65 around the side of the substrate 30, respectively From the upper and lower sides, the first-micro flow channel 64 and the second flow port 63 and the first flow port are illusory. If the substrate 30 is dry, the nucleic acid solution to be analyzed is more rapidly attracted to the capillary phenomenon generated by the micropores of the matrix 30, and is introduced into the pores inside the matrix 30. Thereafter, the nucleic acid to be analyzed may be fixed to the substrate 3 () by using a drying method or by ultraviolet light = ",, the inch surface and the inside thereof. The surface of the table 21 200808963 about several minutes" causes the probe to be searched for the phase. After the nucleic acid to be analyzed is paired, the hybridization reaction step of base pairing can be completed. ★ After that, the probe nucleic acid solution P is injected into the flow port 62 to perform the heterogeneous pairing reaction. The probe nucleic acid solution p after the addition, as in the flow path of the nucleic acid solution T to be analyzed in the first embodiment, can be spread over the entire substrate %. If the substrate is also in a dry state before the addition of the reincarnation p, then the probe nucleic acid solution P quickly enters the interior of the base f 3Q. After adding the probe nucleic acid solution P, the biochip is placed at an appropriate temperature (for example, HC)

雜交配對反應之後,可由第四流通σ勘注入清洗 溶液W,清洗溶液…經過第二微流道64、第三流通口 2〇21 與201卜進人雜交室61巾,如前所述清洗溶液w可由基 質30底部中心點進入基質30内部,並往基質3〇外緣流 動擴散,最後集中於環繞基質30側邊之空隙65内,而分 別由上下兩側之第一微流道64與第二流通口 63排出,部 分則由第一流通口 62排出。由於清洗時,清洗溶液…係 由整個基質30下表面進入内部沖刷,因此能夠輕易地將 較小分子之探針核酸由基質30之孔洞中沖出,進而降低 其背景雜訊值,並縮短沖洗所需時間。 依據眾所周知之聚合酶連鎖反應(P〇lymerase chain reaction,PCR),引子(primer)與待分析核酸之配對 (annealing)時間僅需不到1分鐘即可完成。因此,於本 發明之結構下,探針核酸進入或碰觸基質後,能夠在相當 短的時間内於基質内部或部分表面擴散完全,並與相配對 之待分析核酸完成鹼基配對,因而能夠大幅縮短習知雜交 22 200808963After the hybridization pairing reaction, the cleaning solution W can be injected from the fourth flow σ, and the cleaning solution is passed through the second microchannel 64, the third flow port 2〇21 and 201 into the human hybrid chamber 61, and the solution is washed as described above. w may enter the interior of the substrate 30 from the center point of the bottom of the substrate 30, and flow and diffuse toward the outer edge of the substrate 3, and finally concentrate in the gap 65 around the side of the substrate 30, and the first microchannels 64 and the upper and lower sides respectively The two flow ports 63 are discharged, and the portions are discharged from the first flow port 62. Since the cleaning solution is cleaned from the lower surface of the entire substrate 30 during cleaning, the probe nucleic acid of the smaller molecule can be easily flushed out of the pores of the matrix 30, thereby reducing the background noise value and shortening the flushing. Time required. According to the well-known P〇lymerase chain reaction (PCR), the pairing time of the primer and the nucleic acid to be analyzed can be completed in less than one minute. Therefore, under the structure of the present invention, after the probe nucleic acid enters or touches the substrate, it can diffuse completely inside or part of the surface in a relatively short period of time, and complete base pairing with the paired nucleic acid to be analyzed, thereby enabling Significantly shortened the familiar hybrid 22 200808963

花費十數小時之時間,而於數分鐘内完成。另— 該汽+^缺猶與待分析髓之配對仙#迅速,故 =、’、、:酸於極短之雜加反應時間内並不易附著於基質 可去-且巧洗'合液冲洗時’清洗溶液得沖入基質内部,因而 二易,掉錄質轉-性結合且分子較〃、之探針核 而錢&低背景雜訊之雜交反應結果。此外,前述各 T、t物晶片實_應麟雜交反斜,待分析核酸溶i 口衣針核酸溶液p與清洗溶液w所選擇之注入口或流出 ,係例7F ’其亦可由其他流通口注人,祕其餘流通口 徘出。 【圖式簡單說明】 第 A圖係本發明實施例之立體分解示意圖。 第一 B圖係本發明實施例組設後之剖面示意圖。 第一 C圖係本發明實施例組設後之俯視示意圖。 第一 D圖係本發明實施例進行雜交反應時溶液流向之示 意圖。 第二A圖係本發明第二實施例之立體分解示意圖。 第二B圖係本發明第二實施例組設後之剖面示意圖。 第二C圖係本發明第二實施例組設後之俯視示意圖。 第一 D圖係本發明第二實施例進行雜交反應時溶液流向 之不意圖。 第三A圖係本發明第三實施例之立體分解示意圖。 23 200808963 第三B圖係本發明第三實施例組設後之剖面示意圖。 第三C圖係本發明第三實施例組設後之俯視示意圖。 第三D圖係本發明第三實施例進行雜交反應時溶液流向 之示意圖。 第四A圖係本發明第四實施例之立體分解示意圖。 第四B圖係本發明第四實施例組設後之剖面示意圖。 第四C圖係本發明第四實施例組設後之俯視示意圖。 第四D圖係本發明第四實施例進行雜交反應時溶液流向 之示意圖。 【主要元件符號說明】 10 上基板 11 雜交室 12 第一流通口 13 第二流通口 14 第一微流道 15 空隙 20 下基板 201 頂基板 2011 第三流通口 202 底基板 2021 第三流通口 2022 第二微流道 2023 第四流通口 30 基質 40 上基板 41 雜交室 411 小凸柱 24 200808963 42 第一流通口 43 44 第一微流道 45 50 上基板 51 雜交室 511 52 第一流通口 53 54 第一微流道 55 60 上基板 61 雜交室 62 63 第二流通口 64 65 空隙 T 待分析核酸溶液 P 探針核酸溶液 W 清洗溶液 第二流通口 空隙 小凸柱 第二流通口 空隙 第一流通口 第一微流道 25It takes ten hours and is completed in a few minutes. Another - the steam + ^ lack of judging and the analysis of the marrow to be paired Xian # rapid, so =, ',,: acid in a very short mixed reaction time and not easy to adhere to the substrate can go - and smart wash 'liquid rinse When the 'cleaning solution' is washed into the interior of the matrix, it is easy to remove the mass-transformation and the molecular weight of the probe, and the hybridization reaction of the low background noise. In addition, the above-mentioned T, t material wafers are _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Injecting people, the rest of the circulation is out. BRIEF DESCRIPTION OF THE DRAWINGS FIG. A is a perspective exploded view of an embodiment of the present invention. The first B diagram is a schematic cross-sectional view of the embodiment of the present invention. The first C diagram is a schematic top view of the embodiment of the present invention after being assembled. The first D is an illustration of the flow of the solution in the hybridization reaction of the examples of the present invention. Figure 2A is a perspective exploded view of a second embodiment of the present invention. The second B is a schematic cross-sectional view of the second embodiment of the present invention. The second C is a schematic plan view of the second embodiment of the present invention after being assembled. The first D diagram is not intended to flow the solution in the hybridization reaction of the second embodiment of the present invention. The third A is a perspective exploded view of the third embodiment of the present invention. 23 200808963 The third B is a schematic cross-sectional view of the third embodiment of the present invention. The third C diagram is a schematic plan view of the third embodiment of the present invention after being assembled. The third D is a schematic view showing the flow direction of the solution in the hybridization reaction of the third embodiment of the present invention. Figure 4A is a perspective exploded view of a fourth embodiment of the present invention. The fourth B is a schematic cross-sectional view of the fourth embodiment of the present invention. The fourth C is a schematic plan view of the fourth embodiment of the present invention after being assembled. The fourth D diagram is a schematic diagram showing the flow direction of the solution in the hybridization reaction of the fourth embodiment of the present invention. [Main component symbol description] 10 Upper substrate 11 Hybridization chamber 12 First flow port 13 Second flow port 14 First micro flow path 15 Void 20 Lower substrate 201 Top substrate 2011 Third flow port 202 Base substrate 2021 Third flow port 2022 Second micro flow channel 2023 fourth flow port 30 substrate 40 upper substrate 41 hybridization chamber 411 small stud 24 200808963 42 first flow port 43 44 first micro flow channel 45 50 upper substrate 51 hybridization chamber 511 52 first flow port 53 54 first microchannel 55 60 upper substrate 61 hybridization chamber 62 63 second flow port 64 65 gap T nucleic acid solution to be analyzed P probe nucleic acid solution W cleaning solution second flow port gap small stud second flow port gap first Flow port first micro flow channel 25

Claims (1)

200808963 十、申請專利範圍: 1、一種生物晶片,包括: 該生物晶片内所設呈空腔狀之一雜交室,該雜交室内夾設 有一具孔洞之基質,該雜交室分別連通設置有至少一第一 流通口與至少一第二流通口,藉以使反應溶液由其中至少 一流通口注入後流經該基質内部而由其餘至少一流通口流 _ 2、如申請專利範圍第1項所述之生物晶片,該生物晶片包括 一上基板與一下基板,該上基板與該下基板係上下相疊合 連接’該二者間形成有該雜交室,該雜交室内夾設有具孔 洞之該基質,該雜交室向該上基板連通有至少一該第_流 通口 ’該雜交室於側邊則連通有至少一該第二流通口 ^ 3、如申請專利範圍第2項所述之生物晶片,其中該基質與該 雜交室之一側壁間係留有一預定寬度之空隙。 ⑩ 4、如f請專纖圍第2項所述之生物“,其巾該雜交室係 壬圓盔工I狀,而該第一流通口係連通開設於該雜交室中 心點處之上方。 5、 如申請專利範圍第2項所述之生物晶片,其中該雜交室係 :四邊體空腔狀,而該第―流通口係連通開設於該雜交室 中心點處之上方。 6、 如”專利範圍第2項所述之生物晶片,其中該第二流通 口㈣雜交室間進-步連通接設有—第-微流道。 26 200808963 7、 如申請專利範圍第2項所述之生物晶片,其中該基質之孔 洞直徑係0.1至50 μπι。 8、 如申請專利範圍第2或7項所述之生物晶片,其中該基質 _ 係呈乾燥狀。 , 9、如申請專利範圍第2或7項所述之生物晶片,其中該基質 係—尼龍膜(nylon membrane )。 馨 10、如申請專利範園第2或7項所述之生物晶片,其中該基質 係一硝化纖維紙(nitr〇cellul〇se )。 11、 如申請專利範圍第2項所述之生物晶片,其中該雜交室向 该下基板進一步連通有至少一第三流通口。 12、 如申請專利範圍第n項所述之生物晶片,其中該下基板 進一步係由一頂基板與一底基板上下相疊合連接所組構, 该第三流通口則係形成於該頂基板與該底基板之間。 • 13、如申請專利範圍第Π或12項所述之生物晶片,其中該第 ; f流通口進―步延伸連接有—第二微流道,該第二微流道 並連通設置有一第四流通口。 ’ 14、如帽專利範圍第2項所述之生物“,其中該第一流通 口與該雜交賴進-步連通接設有—第三微流道。 15、一種生物晶片,包括: -上基板與-T基板’該上基板_下基板係上下相疊合遠 接,該二者間形成有一雜交室,該雜交室内上下夹設有〆 27 200808963 具孔洞之基質,該上基板底緣於與該雜交室相接處突出有 複數個小凸柱,該些小凸柱端部係與裝設於該雜交室内之 該基質表面相觸接,此外,該雜交室向該上基板連通有至 少一第一流通口,該雜交室於側邊則連通有至少一第二流 通口,該第二流通口係與該些小凸柱間所間隔之空間相連 通。200808963 X. Patent application scope: 1. A biochip comprising: a hybrid chamber in a cavity shape in the biochip, wherein the hybrid chamber is provided with a matrix of holes, and the hybrid chambers are respectively connected with at least one a first flow port and at least one second flow port, wherein the reaction solution is injected from at least one of the flow ports and then flows through the interior of the substrate to flow from the remaining at least one flow port. 2, as described in claim 1 a biochip comprising an upper substrate and a lower substrate, wherein the upper substrate and the lower substrate are vertically connected to each other; the hybridization chamber is formed therebetween, and the substrate is provided with a hole in the hybrid chamber. The hybridization chamber is connected to the upper substrate with at least one of the first flow ports. The hybridization chamber is connected to at least one of the second flow ports at the side, and the biochip according to claim 2, wherein A gap of a predetermined width is anchored between the substrate and one of the sidewalls of the hybridization chamber. 10 4. If f is the organism mentioned in the second item, the hybrid chamber is in the shape of a round helmet, and the first circulation port is connected above the center of the hybrid chamber. 5. The biochip according to claim 2, wherein the hybrid chamber is a quadrangular cavity, and the first flow port is connected above a center point of the hybrid chamber. The biochip according to the second aspect of the invention, wherein the second flow port (four) is connected to the first microfluidic channel in a stepwise communication manner. The biochip of claim 2, wherein the substrate has a hole diameter of 0.1 to 50 μm. 8. The biochip of claim 2, wherein the substrate is in a dry state. 9. The biochip of claim 2, wherein the substrate is a nylon membrane. The biochip according to the second or seventh aspect of the patent application, wherein the substrate is a nitrulized fiber paper (nitr〇cellul〇se). 11. The biochip of claim 2, wherein the hybrid chamber further communicates with the lower substrate with at least one third flow port. 12. The biochip of claim n, wherein the lower substrate is further formed by a top substrate and a bottom substrate stacked one above another, wherein the third flow port is formed on the top substrate. Between the base substrate and the base substrate. 13. The biochip according to claim 12 or 12, wherein the first f flow port is further connected with a second micro flow channel, and the second micro flow channel is connected to have a fourth Circulation. 14. The organism of claim 2, wherein the first flow port is connected to the hybrid-step-connected third micro flow channel. 15. A biochip comprising: The substrate and the -T substrate 'the upper substrate_lower substrate are superposed on each other, and a hybridization chamber is formed therebetween. The hybrid chamber is provided with a substrate of holes 27 200808963, and the bottom edge of the upper substrate is And a plurality of small protrusions protruding from the hybrid chamber, wherein the small protrusion ends are in contact with the surface of the substrate disposed in the hybrid chamber, and further, the hybrid chamber is connected to the upper substrate by at least one The first flow port has at least one second flow port connected to the side of the hybrid chamber, and the second flow port is in communication with a space between the small protrusions. 16、如申請專利範圍第15項所述之生物晶片,其中該基質與 該雜交室之一側壁間係留有一預定寬度之空隙。 7如申明專利範圍第15項所述之生物晶片,其中該第二流 通口與該雜交室間進—步連通接設有-第-微流道。 18、 如中請專利範圍第15項所述之生物晶片,其中該雜交室 向該下基板進-步連通至少有一第三流通口。The biochip of claim 15, wherein the substrate and the sidewall of one of the hybrid chambers are each provided with a gap of a predetermined width. 7. The biochip of claim 15, wherein the second flow port and the hybridization chamber are in communication with the first-microchannel. 18. The biochip of claim 15, wherein the hybridization chamber is further connected to the lower substrate with at least a third flow port. 19、 如中請專利範_ 18項所述之生物晶片,其中該下基板 進I步係由—頂基板與一底基板上下相疊合連接所組構, 5亥弟二流通口則係形成於該頂基板與該底基板之間。 2〇、如申請專利範圍第18或19項所述之生物晶片,其中該第 三流通口進—步延伸連接有一第二微流道,該第二微流道 並連通設置有1赠通π。 21請口專利範圍第18或19項所述之生物晶片,其中該雜 二系王圓i空腔狀,而該第三流通口係連通開設於★亥雜 交室中心點處之下方。 ” 28 200808963 22、 如申請專利範圍第18或19項所述之生物晶片,其中該雜 交室係呈四邊體空腔狀,而該第三流通口係連通開設於該 雜交室中心點處之下方。 23、 如申請專利範圍第15項所述之生物晶片,其中該第一流 通口與該雜交室間進一步連通接設有一第三微流道。 24、 如申請專利範圍第15項所述之生物晶片,其中該基質之 孔洞直徑係0.1至50 μπι。 25、 如申請專利範圍第15或24項所述之生物晶片,其中該基 質係呈乾燥狀。 26、 如申請專利範圍第15或24項所述之生物晶片,其中該基 質係一尼龍膜。 27、 如申請專利範圍第15或24項所述之生物晶片,其中該基 質係一硝化纖維紙。 2919. The biochip according to claim 18, wherein the lower substrate is stepped by a top substrate and a bottom substrate, and the fifth channel is formed. Between the top substrate and the base substrate. The biochip according to claim 18 or 19, wherein the third flow port is further connected to a second micro flow channel, and the second micro flow channel is connected and provided with a gift π. . The biological wafer of claim 18 or 19, wherein the heterogeneous system is in the form of a cavity, and the third flow port is connected to the lower side of the center of the intersection. The biochip of claim 18 or 19, wherein the hybrid chamber is in the shape of a quadrilateral cavity, and the third flow port is connected below the center of the hybrid chamber. The biochip according to claim 15, wherein a third microchannel is further connected between the first flow port and the hybrid chamber. 24. According to claim 15 The biochip, wherein the substrate has a pore diameter of 0.1 to 50 μm. 25. The biochip according to claim 15 or claim 24, wherein the substrate is in a dry form. 26, as claimed in claim 15 or 24. The biochip of the present invention, wherein the substrate is a nylon film. The biochip of claim 15 or claim 24, wherein the substrate is a nitrocellulose paper.
TW95129607A 2006-08-11 2006-08-11 Biological wafer TWI396740B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW95129607A TWI396740B (en) 2006-08-11 2006-08-11 Biological wafer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW95129607A TWI396740B (en) 2006-08-11 2006-08-11 Biological wafer

Publications (2)

Publication Number Publication Date
TW200808963A true TW200808963A (en) 2008-02-16
TWI396740B TWI396740B (en) 2013-05-21

Family

ID=44767005

Family Applications (1)

Application Number Title Priority Date Filing Date
TW95129607A TWI396740B (en) 2006-08-11 2006-08-11 Biological wafer

Country Status (1)

Country Link
TW (1) TWI396740B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126294A1 (en) * 2011-03-22 2012-09-27 博奥生物有限公司 Biological chip hybridization system
TWI809755B (en) * 2022-03-11 2023-07-21 南亞科技股份有限公司 Wafer structure for holding biochips and method for cleaning biochips using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126294A1 (en) * 2011-03-22 2012-09-27 博奥生物有限公司 Biological chip hybridization system
US9677133B2 (en) 2011-03-22 2017-06-13 Capitalbio Corporation Biological chip hybridization system
TWI809755B (en) * 2022-03-11 2023-07-21 南亞科技股份有限公司 Wafer structure for holding biochips and method for cleaning biochips using the same

Also Published As

Publication number Publication date
TWI396740B (en) 2013-05-21

Similar Documents

Publication Publication Date Title
US9671317B2 (en) Automatic injection device for microarray chip and automatic injection hybridization microarray chip
Xu et al. Aptamers in microfluidic chips
US20050142565A1 (en) Nucleic acid purification chip
CN101358912B (en) Three-dimensional microflow control chip containing in-situ poly(butyl methacrylate) preprocess integral column
EP2440330A1 (en) Picowell capture devices for analysing single cells or other particles
CN101948741A (en) Microfluidic gene chip for nucleic acid sequencing
TWI331680B (en)
US9862987B2 (en) Label free molecular detection methods, systems and devices
CN107603849B (en) Single cell RT-PCR chip and preparation method thereof
WO2013126556A1 (en) Ultrahigh throughput microinjection device
CN111796104A (en) Exosome detection and typing microfluidic chip and exosome detection and typing method
JP2021509024A (en) Capturing a large number of droplets
CN104561286B (en) A kind of novel polymeric enzyme chain reaction micro-fluid chip control system and preparation method thereof
KR101355994B1 (en) Microdevice for pathogen detection
JPWO2016084489A1 (en) Spot array substrate, manufacturing method thereof, nucleic acid polymer analysis method and apparatus
CN109847818A (en) A kind of high throughput microarray detection chip and preparation method thereof, application method
Chang et al. A microchannel immunoassay chip with ferrofluid actuation to enhance the biochemical reaction
TW200808963A (en) Biochip
WO2017062901A2 (en) Methods to isolate extracellular vesicles in biofluids for biomarker discovery and disease diagnosis
Chou Microfabricated Devices for Rapid DNA Diagnostics
KR101573501B1 (en) Cell separation chip and its separaion method of cell
Sun et al. Microfluidics‐Molded Through‐Hole Membranes for 3D Culture Array‐Based Tumor Manipulation and Analysis
CN103360459B (en) Method of protein crystallization and open constant current diffusible proteins matter crystalline arrays chip of constant current diffusion and preparation method thereof and application
CN216149778U (en) Micro-fluidic chip
US10378054B2 (en) Sol-gel chip using porous substrate for entrapping small molecules and screening method of small molecules specific material using thereof